Cat. No. | Product name | CAS No. |
DC20686 |
AS602868
A potent, selective and ATP-competitive inhibitor of IKK2 with IC50 of 60 nM and Ki of 20 nM, also interfers directly with FLT3 kinase activation. |
219773-55-4 |
DC22817 |
RUSKI-201
A potent, selective and cell active Hedgehog acyltransferase (Hhat) inhibitor with IC50 of 0.87 uM. |
1458031-48-5 |
DC11820 |
A-893
A potent, selective and cell active lysine methyltransferase SMYD2 inhibitor with IC50 of 2.8 nM. |
1868232-32-9 |
DC22867 |
HR22C16
A potent, selective and cell permeable inhibitor of mitotic kinesin Eg5 with IC50 of 0.8 uM, does not interact with other microtubule motor proteins. |
462630-41-7 |
DC20309 |
ANTISAUVAGINE-30
Featured
A potent, selective and competitive corticotropin-releasing factor CRF2 receptor antagonist with Ki of 1.4 nM, 100-fold selectiivity over CRF1. |
220673-95-0 |
DC11979 |
SB 332235
A potent, selective and competitive CXCR2 inhibitor that selectively inhibits CXCR2-mediated recruitment of β-arrestin-2 with pKi of 8.92. |
276702-15-9 |
DC11755 |
L-732138
Featured
A potent, selective and competitive NK1 receptor antagonist with IC50 of 2.3 nM. |
148451-96-1 |
DC22763 |
Rilapladib
A potent, selective and oral lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.23 nM, for the treatment of Alzheimer's disease and atherosclerosis.. |
412950-08-4 |
DC21210 |
Rolofylline
A potent, selective and orally active adenosine A1 receptor antagonist with Ki of 1.3 nM. |
136199-02-5 |
DC21827 |
XE 991 dihydrochloride
Featured
A potent, selective and orally active blocker of voltage-gated potassium channels Kv7 (KCNQ) that blocks KCNQ1, KCNQ2 and KCNQ2+KCNQ3 with Kd of 0.78, 0.7 and 0.6 uM, respectively. |
122955-13-9 |
DC23371 |
NI-42
Featured
NI-42 is a potent, selective and orally active BRPF1 bromodomain inhibitor with IC50 of 7.9 nM, with excellent selectivity over nonclass IV BRDs; weakly inhibits BRPF2 (BRD1), BRPF3, BRD9 and BRD4 (BD1) with IC50 of 48, 260, 310 and 4500 nM respectively, and no activity for ATAD2A/2B (IC50>100 uM); shows a modest (GI50=1-10 uM) and selective inhibition of proliferation of certain cancer lines, particularly those lines exhibiting monocytic lineage differentiation; a novel, structurally orthogonal chemical probe for the BRPFs suitable for cellular and in vivo studies. |
1884640-99-6 |
DC11710 |
GDC-0425
A potent, selective and orally active Chk1 inhibitor. |
1200129-48-1 |
DC24158 |
Rofecoxib
A potent, selective and orally active COX-2 inhibitor with IC50 of 26 nM for inhibition of the COX-2-dependent production of PGE2 in human osteosarcoma cells. |
162011-90-7 |
DC20810 |
Pexacerfont
A potent, selective and orally active CRF1 receptor antagonist with IC50 of 6.1 nM, >1,000-fold selectivity over CRF-binding protein and biogenic amine receptors. |
459856-18-9 |
DC20923 |
CP 376395 hydrochloride
A potent, selective and orally active CRF1 receptor antagonist with Ki of 12 nM, shows no affinity for CRF2 receptor (Ki>10 uM). |
1013933-37-3 |
DC20689 |
ASB 14780
A potent, selective and orally active cytosolic phospholipase A2α (cPLA2α) inhibitor with IC50 of 20 nM. |
1069046-00-9 |
DC11868 |
Freselestat
A potent, selective and orally active human neutrophil elastase (HNE) inhibitor with Ki of 12 nM. |
208848-19-5 |
DC21689 |
SR 142948A
Featured
A potent, selective and orally active neurotensin receptor antagonist with IC50 of 1.19 nM. |
184162-21-8 |
DC23621 |
YM543
A potent, selective and orally active SGLT2 inhibitor with IC50 of 8.9 nM, 280-fold selectivity over SGLT1. |
1174340-24-9 |
DC11514 |
Atogepant
A potent, selective and orally available CGRP receptor antagonist for the prevention of migraine. Migraine. |
1374248-81-3 |
DC21842 |
Darexaban
A potent, selective and orally available factor Xa (FXa) inhibitor with IC50 of 54.6 nM. |
365462-23-3 |
DC21718 |
T-3364366
A potent, selective and orally available inhibitor of delta-5 desaturase (D5D) with Ki of <2.7 nM and IC50 of 19 nM, with excellent selectivity over D6D and SCD. |
1356354-09-0 |